End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 USD | 0.00% | 0.00% | +16.29% |
May. 21 | Alvotech Signs Commercialization Deal for Prolia, Xgeva Biosimilar | MT |
May. 21 | Alvotech and Dr. Reddy's Partner to Commercialize Biosimilar Candidate Denosumab | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.29% | 3.9B | |
+44.48% | 55.07B | |
+43.57% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent